Customizing biomimetic surface attributes of dendritic lipopeptide nanoplatforms for extended circulation
Copyright © 2023 Elsevier Inc. All rights reserved..
The pressing demand for innovative approaches to create delivery systems with heightened drug loading and prolonged circulation has spurred numerous efforts, yielding some successes but accompanied by constraints. Our study proposes employing dendritic lipopeptide with precisely balanced opposing charges to extend blood residency for biomimetic nanoplatforms. Neutrally mixed-charged zwitterionic nanoparticles (NNPs) achieved a notable 19 % simvastatin loading content and kept stable even after one-month storage at 4 °C. These nanoplatforms demonstrated low cytotoxicity in NIH-3T3 and L02 cells and negligible hemolysis (<5 %). NNPs inhibited protein adhesion (>95 %) from positively and negatively charged sources through surface hydration. In comparison to positively charged CNPs, NNPs demonstrated an 86 % decrease in phagocytic rate by BMDMs, highlighting their efficacy. Importantly, NNPs showed prolonged circulation compared to CNPs and free simvastatin. These findings highlight the potential of this biomimetic nanoplatform for future therapeutic applications with enhanced drug loading and circulation traits.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
---|---|
Enthalten in: |
Nanomedicine : nanotechnology, biology, and medicine - 56(2024) vom: 15. Feb., Seite 102726 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wei, Jingjing [VerfasserIn] |
---|
Links: |
---|
Themen: |
AGG2FN16EV |
---|
Anmerkungen: |
Date Completed 06.02.2024 Date Revised 06.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.nano.2023.102726 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365432938 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365432938 | ||
003 | DE-627 | ||
005 | 20240206232032.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nano.2023.102726 |2 doi | |
028 | 5 | 2 | |a pubmed24n1282.xml |
035 | |a (DE-627)NLM365432938 | ||
035 | |a (NLM)38052371 | ||
035 | |a (PII)S1549-9634(23)00077-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wei, Jingjing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Customizing biomimetic surface attributes of dendritic lipopeptide nanoplatforms for extended circulation |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.02.2024 | ||
500 | |a Date Revised 06.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a The pressing demand for innovative approaches to create delivery systems with heightened drug loading and prolonged circulation has spurred numerous efforts, yielding some successes but accompanied by constraints. Our study proposes employing dendritic lipopeptide with precisely balanced opposing charges to extend blood residency for biomimetic nanoplatforms. Neutrally mixed-charged zwitterionic nanoparticles (NNPs) achieved a notable 19 % simvastatin loading content and kept stable even after one-month storage at 4 °C. These nanoplatforms demonstrated low cytotoxicity in NIH-3T3 and L02 cells and negligible hemolysis (<5 %). NNPs inhibited protein adhesion (>95 %) from positively and negatively charged sources through surface hydration. In comparison to positively charged CNPs, NNPs demonstrated an 86 % decrease in phagocytic rate by BMDMs, highlighting their efficacy. Importantly, NNPs showed prolonged circulation compared to CNPs and free simvastatin. These findings highlight the potential of this biomimetic nanoplatform for future therapeutic applications with enhanced drug loading and circulation traits | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biomimetic surface | |
650 | 4 | |a Dendritic lipopeptide | |
650 | 4 | |a Long circulation | |
650 | 4 | |a Systemic delivery | |
650 | 4 | |a Zwitterionic | |
650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
650 | 7 | |a Simvastatin |2 NLM | |
650 | 7 | |a AGG2FN16EV |2 NLM | |
700 | 1 | |a Zhou, Yin |e verfasserin |4 aut | |
700 | 1 | |a He, Yiyan |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Wentao |e verfasserin |4 aut | |
700 | 1 | |a Luo, Zhiqiang |e verfasserin |4 aut | |
700 | 1 | |a Yang, Jian |e verfasserin |4 aut | |
700 | 1 | |a Mao, Hongli |e verfasserin |4 aut | |
700 | 1 | |a Gu, Zhongwei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 56(2024) vom: 15. Feb., Seite 102726 |w (DE-627)NLM16062021X |x 1549-9642 |7 nnns |
773 | 1 | 8 | |g volume:56 |g year:2024 |g day:15 |g month:02 |g pages:102726 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2023.102726 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 56 |j 2024 |b 15 |c 02 |h 102726 |